Surgical treatment of malignant pleural mesothelioma: A review

Chest

Volumn 123, Issue 2, 2003, Pages 551-561

  Van Ruth, Serge ^a   Baas, Paul ^a   Zoetmulder, Frans A N ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Adjuvant therapy; Mesothelioma; Pleural cavity; Review; Surgery

Indexed keywords

3 TETRAHYDROXYPHENYLCHLORIN; ALPHA INTERFERON; CHLORINE DERIVATIVE; CISPLATIN; CYTARABINE; DOXORUBICIN; MITOMYCIN C; PHOTOFRIN; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL RESEARCH; CLINICAL TRIAL; HUMAN; HYPERTHERMIA; LUNG RESECTION; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MULTIMODALITY CANCER THERAPY; NEPHROTOXICITY; PATIENT CARE; PHOTODYNAMIC THERAPY; PLEURA CAVITY; PLEURA MESOTHELIOMA; PLEURECTOMY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL TECHNIQUE; SURVIVAL TIME; THORACOTOMY; THORAX SURGERY; TOXICITY; TREATMENT OUTCOME;

EID: 0037331829     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.2.551     Document Type: Review

References (92)

1. Moskal TL, Urschel JD, Anderson TM, et al. Malignant pleural mesothelioma: a problematic review. Surg Oncol 1998; 7:5-12
2. Pass HI, Pogrebniak HW. Malignant pleural mesothelioma. Curr Probl Surg 1993; 30:921-1012
3. Aisner J. Current approach to malignant mesothelioma of the pleura. Chest 1995; 107:332S-344S
4. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma: a randomized trial of local radiotherapy. Chest 1995; 108:754-758
5. Hillerdal G. Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest 1983; 77:321-343
6. Janssen-Heijnen ML, Damhuis RA, Klinkhamer PJ, et al. Increased but low incidence and poor survival of malignant mesothelioma in the southeastern part of the Netherlands since 1970: a population-based study. Eur J Cancer Prev 1999; 8:311-314
7. Muscat JE, Wynder EL. Cigarette smoking, asbestos exposure, and malignant mesothelioma. Cancer Res 1991; 51:2263-2267
8. Antman KH. Natural history and epidemiology of malignant mesothelioma. Chest 1993; 103:373S-376S
9. Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin Oncol 2002; 29:2-17
10. Calavrezos A, Koschel G, Husselmann H, et al. Malignant mesothelioma of the pleura: a prospective therapeutic study of 132 patients from 1981-1985. Klin Woehenschr 1988; 66:607-613
11. Ruffie P, Feld R, Minkin S, et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 1989; 7:1157-1168
12. Baas P, Schouwink H, Zoetmulder FA. Malignant pleural mesothelioma. Ann Oncol 1998; 9:139-149
13. Rusch VW. Clinical features and current treatment of diffuse malignant pleural mesothelioma. Lung Cancer 1995; 12(Suppl 2):S127-S146
14. Ong ST, Vogelzang NJ. Chemotherapy in malignant pleural mesothelioma: a review. J Clin Oncol 1996; 14:1007-1017
15. Sterman DH, Kaiser LR, Albelda SM. Advances in the treatment of malignant pleural mesothelioma. Chest 1999; 116:504-520
16. Gordon W, Antman KH, Greenberger JS, et al. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys 1982; 8:19-25
17. Bissett D, Macbeth FR, Cram I. The role of palliative radiotherapy in malignant mesothelioma. Clin Oncol (R Coll Radiol) 1991; 3:315-317
18. Lee YC, Light RW, Musk AW. Management of malignant pleural mesothelioma: a critical review. Curr Opin Pulm Med 2000; 6:267-274
19. Ho L, Sugarbaker DJ, Skarin AT. Malignant pleural mesothelioma. Cancer Treat Res 2001; 105:327-373
20. Rusch VW. Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma. Chest 1993; 103:382S-384S
21. Rusch VW, Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. Thorac Cardiovasc Surg 1996; 111:815-825
22. Butchart EG, Ashcroft T, Barnsley WC, et al. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients. Thorax 1976; 31:15-24
23. Sugarbaker DJ, Strauss GM, Lynch TJ, et al. Node status has prognostic significance in the multimodality, therapy of diffuse, malignant mesothelioma. J Clin Oncol 1993; 11:1172-1178
24. Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma: The International Mesothelioma Interest Group. Chest 1995; 108:1122-1128
25. Maasilta P, Vehmas T, Kivisaari L, et al. Correlations between findings at computed tomography (CT) and at thoracoscopy/thoracotomy/autopsy in pleural mesothelioma. Eur Respir J 1991; 4:952-954
26. Conlon KC, Rusch VW, Gillern S. Laparoscopy: an important tool in the staging of malignant pleural mesothelioma. Ann Surg Oncol 1996; 3:489-494
27. Heelan RT, Rusch VW, Begg CB, et al. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR Am J Roentgenol 1999; 172:1039-1047
28. Rusch VW, Venkatraman ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 1999; 68:1799-1804
29. Benard F, Sterman D, Smith RJ, et al. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest 1998; 114:713-722
30. Patz EF Jr, Shaffer K, Piwnica-Worms DR, et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol 1992; 159:961-966
31. Pass HI, Temeck BK, Kranda K, et al. Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma. Thorac Cardiovasc Surg 1998; 115:310-317
32. Sugarbaker DJ, Garcia JP, Richards WG, et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 consecutive patients. Ann Surg 1996; 224:288-294
33. Boutin C, Rey F, Gouvernet J, et al. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients; part 2: prognosis and staging. Cancer 1993; 72:394-404
34. Rusch VW. Pleurectomy/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 1997; 9:367-372
35. Soysal O, Karaoglanoglu N, Demiracan S, et al. Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery. Eur J Cardiothorac Surg 1997; 11:210-213
36. Chahinian AP, Pajak TF, Holland JF, et al. Diffuse malignant mesothelioma: prospective evaluation of 69 patients. Ann Intern Med 1982; 96:746-755
37. Brenner J, Sordillo PP, Magill GB, et al. Malignant mesothelioma of the pleura: review of 123 patients. Cancer 1982; 49:2431-2435
38. Law MR, Gregor A, Hodson ME, et al. Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax 1984; 39:255-259
39. Chailleux E, Dabouis G, Pioche D, et al. Prognostic factors in diffuse malignant pleural mesothelioma: a study of 167 patients. Chest 1988; 93:159-162
40. Brancatisano RP, Joseph MG, McCaughan BC. Pleurectomy for mesothelioma. Med J Aust 1991; 154:455-457,460
41. Rusch VW, Piantadosi S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma: Lung Cancer Study Group trial. Thorac Cardiovasc Surg 1991; 102:1-9
42. Allen KB, Faber LP, Warren WH. Malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy. Chest Surg Clin N Am 1994; 4:113-126
43. Ceresoli GL, Locati L, Ferreri AJ, et al. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer 2001; 34:279-287
44. Hilaris BS, Nori D, Kwong E, et al. Pleurectomy and intraoperative brachytherapy and postoperative radiation in the treatment of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 1984; 10:325-331
45. Sugarbaker DJ, Mentzer SJ, DeCamp M, et al. Extrapleural pneumonectomy in the setting of a multimodality approach to malignant mesothelioma. Chest 1993; 103:377S-381S
46. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. Thorac Cardiovasc Surg 1999; 117:54-63
47. Politi L, De Anna D, Navarra G, et al. Extrapleural pneumonectomies with pericardial and diaphragmatic plasty. Minerva Chir 2001; 56:251-255
48. Harpole DH, Liptay MJ, DeCamp MM Jr, et al. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg 1996; 61:977-982
49. Worn H. [Chances and results of surgery of malignant mesothelioma of the pleura (author's translation).] Moglichkeiten und Ergebnisse der chirurgischen Behandlung des malignen Pleuramesothelioms. Thoraxchir Vask Chir 1974; 22:391-393
50. Baldini EH, Recht A, Strauss GM, et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 1997; 63:334-338
51. Rusch VW. Trials in malignant mesothelioma: LCSG 851 and 882. Chest 1994; 106:359S-362S
52. McCormack PM, Nagasaki F, Hilaris BS, et al. Surgical treatment of pleural mesothelioma. Thorac Cardiovasc Surg 1982; 84:834-842
53. Alberts AS, Falkson G, Goedhals L, et al. Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. J Clin Oncol 1988; 6:527-535
54. Mattson K, Holsti LR, Tammilehto L, et al. Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemithorax irradiation. Int J Radiat Oncol Biol Phys 1992; 24:643-650
55. Rusch VW, Rosenzweig K, Venkatraman E, et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. Thorac Cardiovasc Surg 2001; 122:788-795
56. DaValle MJ, Faber LP, Kittle CF, et al. Extrapleural pneumonectomy for diffuse, malignant mesothelioma. Ann Thorac Surg 1986; 42:612-618
57. Huncharek M, Kelsey K, Mark EJ, et al. Treatment and survival in diffuse malignant pleural mesothelioma: a study of 83 cases from the Massachusetts General Hospital. Anticancer Res 1996; 16:1265-1268
58. Hastürk S, Tastepe I, Unlu M, et al. Combined chemotherapy in pleurectomized malignant pleural mesothelioma patients. J Chemother 1996; 8:159-164
59. Rice TW, Adelstein DJ, Kirby TJ, et al. Aggressive multimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 1994; 58:24-29
60. Rusch V, Saltz L, Venkatraman E, et al. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol 1994; 12:1156-1163
61. Sauter ER, Langer C, Coia LR, et al. Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation. J Surg Oncol 1995; 60:100-105
62. Lee JD, Perez S, Wang HJ, et al. Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: the UCLA experience. J Surg Oncol 1995; 60:262-267
63. Colleoni M, Sartori F, Calabro F, et al. Surgery followed by intracavitary plus systemic chemotherapy in malignant pleural mesothelioma. Tumori 1996; 82:53-56
64. Pass HI, Temeck BK, Kranda K, et al. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol 1997; 4:628-633
65. Moskal TL, Dougherty TJ, Urschel JD, et al. Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. Ann Thorac Surg 1998; 66:1128-1133
66. Schonwink H, Rutgers ET, van der Sijp J, et al. Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma: dose finding and toxicity results. Chest 2001; 120:1167-1174
67. Sugarbaker DJ, Jaklitsch MT, Liptay MJ. Mesothelioma and radical multimodality therapy: who benefits? Chest 1995; 107:345S-350S
68. Rubin P, Constine LS, Nelson DF. Late effects of cancer treatment: radiation and drag toxicity. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology. Philadelphia, PA: J.B. Lippincott, 1992;124-161
69. Maasilta P. Deterioration in lung function following hemithorax irradiation for pleural mesothelioma. Int J Radiat Oncol Biol Phys 1991; 20:433-438
70. Grondin SC, Sugarbaker DJ. Pleuropneumonectomy in the treatment of malignant pleural mesothelioma. Chest 1999; 116:450S-454S
71. Mychalczak BR, Nori D, Armstrong JG, et al. Results of treatment of malignant pleural mesothelioma with surgery, brachytherapy, and external beam radiation [abstract]. Endocurie Hypertherm Oncol 1989; 5:245
72. Wanebo HJ, Martini N, Melamed MR, et al. Pleural mesothelioma. Cancer 1976; 38:2481-2488
73. Markman M. Intraperitoneal chemotherapy. Semin Oncol 1991; 18:248-254
74. Bogliolo GV, Lerza R, Bottino GB, et al. Regional pharmacokinetic selectivity of intrapleural cisplatin. Eur J Cancer 1991; 27:839-842
75. Rusch VW, Niedzwiecki D, Tao Y, et al. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies. J Clin Oncol 1992; 10:1001-1006
76. Lerza R, Esposito M, Vannozzi M, et al. High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma: clinical observations and pharmacokinetic analyses. Cancer 1994; 73:79-84
77. van de Vaart PJ, van der Vange N, Zoetmulder FA, et al. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines. Eur J Cancer 1998; 34:148-154
78. Storm FK. Clinical hyperthermia and chemotherapy. Radiol Clin North Am 1989; 27:621-627
79. Los G, van Vugt MJ, Pinedo HM. Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer 1994; 69:235-241
80. Ohtsubo T, Saito H, Tanaka N, et al. In vitro effect of hyperthermia on chemoenhancement and uptake of cisplatin in human pharyngeal carcinoma KB cells. Chemotherapy 1997; 43:43-50
81. Los G, Sminia P, Wondergem J, et al. Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats. Eur J Cancer 1991; 27:472-477
82. Carry PY, Brachet A, Gilly FN, et al. A new device for the treatment of pleural malignancies: intrapleural chemohyperthermia preliminary report. Oncology 1993; 50:348-352
83. Mustafa KY, Selig WM, Burhop KE, et al. Hyperthermia-induced pulmonary edema. J Appl Physiol 1986; 60:1980-1985
84. Yellin A, Simansky DA, Paley M, et al. Hyperthermic pleural perfusion with cisplatin. Cancer 2001; 92:2197-2203
85. Ratto GB, Civalleri D, Esposito M, et al. Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic study. Thorac Cardiovasc Surg 1999; 117:759-765
86. de Bree E, van Ruth S, Baas P, et al. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma. Chest 2002; 121:480-487
87. Hahn GM, Braun J, Har-Kedar I. Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation. Proc Natl Acad Sci U S A 1975; 72:937-940
88. Ozols RF, Locker GY, Doroshow JH, et al. Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer. Cancer Res 1979; 39:3209-3214
89. Takita H, Dougherty TJ. Intracavitary photodynamic therapy for malignant pleural mesothelioma. Semin Surg Oncol 1995; 11:368-371
90. Baas P, Murrer L, Zoetmulder FA, et al. Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies. Br J Cancer 1997; 76:819-826
91. Ris HB, Altermatt HJ, Nachbur B, et al. Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies. Lasers Surg Med 1996; 18:39-45
92. Sterman DH, Treat J, Litzky LA, et al. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma. Hum Gene Ther 1998; 9:1083-1092